Financial insights of ZNTL

MyFinsight

For the quarter ending 2026-03-31.

Income Statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Revenues from licensing and sales of intellectual property	-	0	0	0
Research and development	28,716,000	29,488,000	22,950,000	27,610,000
Zentera in-process research and development	-	0*	-	-
General and administrative	9,139,000	7,905,000	10,784,000	8,448,000
Non-cash items	-	0*	-	-
Accruals	-	1,612,000*	-	-
Non-cash items	-	-1,612,000*	-	-
Restructuring	0	0	0	0
Goodwill impairment	-	0*	-	-
Total operating expenses	37,855,000	37,393,000	33,734,000	36,058,000
Loss from operations	-37,855,000	-37,393,000	-33,734,000	-36,058,000
Investment and other income (expense), net	2,623,000	2,619,000	7,043,000	9,184,000
Net loss before income taxes	-35,232,000	-34,774,000	-26,691,000	-26,874,000
Income tax expense	120,000	442,000*	0	0
Loss on equity method investment	-	0*	-	-
Net loss	-	-35,216,000	-26,691,000	-26,874,000
Net loss attributable to noncontrolling interests	-	0	0	0
Net loss	-35,352,000	-35,216,000	-26,691,000	-26,874,000

Basic EPS	-0.5	-0.491	-0.37	-0.37
Diluted EPS	-0.5	-0.491	-0.37	-0.37
Basic Average Shares	70,264,000	71,667,000	72,139,000	71,992,000
Diluted Average Shares	70,264,000	71,667,000	72,139,000	71,992,000